<SEC-DOCUMENT>0000950103-24-011991.txt : 20240911
<SEC-HEADER>0000950103-24-011991.hdr.sgml : 20240911
<ACCEPTANCE-DATETIME>20240809111307
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950103-24-011991
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADC Therapeutics SA
		CENTRAL INDEX KEY:			0001771910
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		BIOPOLE
		STREET 2:		ROUTE DE LA CORNICHE 3B
		CITY:			EPALINGES
		STATE:			V8
		ZIP:			1066
		BUSINESS PHONE:		41 21 653 02 00

	MAIL ADDRESS:	
		STREET 1:		BIOPOLE
		STREET 2:		ROUTE DE LA CORNICHE 3B
		CITY:			EPALINGES
		STATE:			V8
		ZIP:			1066
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">August 9, 2024</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><U>VIA EDGAR</U></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Securities and Exchange Commission<BR>
Division of Corporation Finance<BR>
100 F Street, N.E.<BR>
Washington, D.C. 20549</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="width: 93%; font-size: 10pt"><FONT STYLE="font-size: 10pt">ADC Therapeutics SA<BR>
Registration Statement on Form S-3<BR>
Registration No. 333-281288</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In accordance with Rule 461 under the Securities Act of 1933, as amended,
we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-281288) (the &ldquo;Registration
Statement&rdquo;) of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:00 p.m.,
Eastern time, on August 13, 2024, or as soon as practicable thereafter.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Once the Registration Statement has been declared effective, please
orally confirm that event with our counsel, Davis Polk &amp; Wardwell LLP, by calling David Li at (212) 450-3861.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Thank you for your assistance in this matter.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">ADC Therapeutics SA</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Peter J. Graham</FONT></TD>
    <TD STYLE="width: 62%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&#9;Peter J. Graham</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-indent: -0.5in; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:&#9;Chief Legal Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !5 )4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH *\=\:?%N]L-?DL- %L\%OE)9I4+[Y.^W!' Z?7-=!\4O&O_"/:5_9=C+C
M4[Q"-RGF&/H6^IZ#\3VKY]Z5ZF#PJDN>:TZ'!B:[B^6+U.__ .%R>+/6P_[\
M'_&NET3XDZ_?Z:L\_P!EWEV'RQ8''XUXW7K7P\\(2ZUX42[2[2(&:1=I0GH:
M[ITL/37-.*L>;6GBJD;46[FV/'FL_P#3O_W[_P#KU9@^(5^A'GVD$@_V25-2
MGX=7..-0B)]XS_C5"[\"ZQ;*6B$-P!VC;!_(UDOJ4M-/R.-_VI3U=_P9T^G^
M.]-NV"7"O;.>[\K^==-'+'-&'C=70]"IR*\/EAD@E:*:-HY%X*N,$5K:%XAN
MM&N%"N7MB?FC)X^HK*MEZMS4G\CHPN<RYN3$+Y_YH]8N+B&TMWN+B5(H8QEG
M<X %><:[\4PKM!HEN' X^TSC@_[J_P"/Y5S'C#Q=/XDOFACWQ6$#82$\%B/X
MF_IZ5SUM:SWMS';6T3RSR'"(@R2:>'P,5'GJ_<7B\RG*7)0V[]_0T[WQ5KU^
MQ,^JW.#_  QOL7\EQ6;]LNRVXW5QN]?-;/\ .O2-%^%:&-9=:NFWGDP6YP!]
M6[_A70CX<^&0FW["Y/KYSY_G6CQF'@[17W(RCE^+J+FD_O9Y-9^)]=L&!M]5
MN@!_"\A=?R;-=MH/Q2)=(-<@4*>/M,(Z?[R_X?E4^K_"JV>)I-(NY(I ,B*<
M[E/MGJ/UKA[#PGK%_K,FEK:-'-$<3-(,)&/4GO[8ZT[X6O%O:WR8DL;A9I*[
MO\T_Z^1[U!/%=0)/!(LD4@W(ZG((HK,\-Z#%X<TA+&*>2;!+,SGC<>N!V'M1
M7AR23:CL?30<G%.2LS7HHHJ2@K)\2^(+3PSH=QJ=V<K&,)&#S(YZ*/K6H[K&
MA=V"JHR23@"O!/'=YK7C?7,6ELR:5:DK;"5@@<]Y"#SSV]OK6E/V?-^\DDO-
MBDJC7[N+;\D<+JVJW>MZK<:E?2;[B=MS>BCLH]@.*Z;3_!Y3X<:KXGOHR"RH
MEDI]-X#2?CT'XTFC> KF75K;^UI(X]/#9G,3;F*C^$#'?IFO4_']W8W7PWU"
MSTX@[(XUCA12"%#KP![ 5Z,\QP[E&G2FMUU.)8&O%2G5BSYZKZ%^#G_(@1_]
M?,O\Z^>N^.]?0OP<_P"1!C_Z^9?YUT8_^%\S#!_Q/D=_1117A'JF-X@\/V^M
MV; JJ72#]U+CD'T/M7DLL3PRO%(I5T8JRGL17N=>5>-;9;?Q-,5&!*BR?CC!
M_E7KY=6?,Z;V/G,[PT>55DM=F</JT(CECN5X#?(_]#7K'P[\-1Z7I":E/&/M
MMVNX$CF.,] /KU-><W%L+N-8#_'(@_\ 'A7O*(L<:H@PJ@ #T%:9C4<8J"ZF
M>2TE-NH^F@ZBBBO$/IPI, $G R>M+10 4444 %8WB#Q)::!;@R?O+EQ^[A4\
MGW/H*D\0:W%H6F/<N TK?+%'G[S?X>M>-:EJ3SRS7]_/EF.7=OY#_"O-QN,=
M*U.DKS9ZV7X!5KU:KM!?C_P.YL7NNZAK<Q:[F/EY^6%.$7\._P"-)!+"+F&V
M,J?:)F"1Q;OF8GL!7G=_XGN908K,F"+^_P#QM_A7J'PB\&M;P?\ "3:BA-S<
M*1:*_)5#U?ZMV]OK3IY)5]G[;%RLWTW?^2+K9U14O8X2-TNNR_S9N1>'-3QD
MVP'U<4R\LI]+MVN+Q1! F-TK,-HR<#)KOJX[XI_\DYU7Z1_^AK2CE-*I)1YF
MKG-/,ZJ3DTCE-4\,Z1KL7F2PH)&'RW$! ;\QP?QKJ?AY9Q:!H/\ 9$ETLDBS
MNZ,1MW*QX_&OGK3]6O\ 2I?,L;N6$]U!^4_4=#7MG@[[?XE\*1:HPC,_F/&R
M)\N=IZBM*^#S'+H^[/VE/MU7]>3^1RTL3A<7+WH\D^_]?J>F45R%OK=]IS>5
M<*9%'&V3AA]#6O;^)=.F $DI@;TD&!^?2G1QM*IN[/LS2IA*L-4KKR-BO,/'
MKAO$FT=4@4']37H<FK:?' \QO("BJ6.'!/Y5Y#JVH'4=4N+R3Y?-?(7J0.@'
MY5[&#K4J4G5J2227<\+-*%>O35"C!RDWT3Z?E\RM"R)/$\C;46123^(KW(?=
M'TKYYUB4BW2#HTK=/11U_I7L_@W7$UWP[;RE@;B%1%.O<,!U_$<U6(E4KKV[
M5H[+O;N_7\K=R<#3I85_54[SWDUM?LN]EN^]^QT%%%%<1ZH4444 %%%% 'GW
MQ/D2*.PDD8*BB0DGL.*\+U34Y-2GSRL"GY$_J?>NY^+OBZ#5]832+)PT%B2)
MI0?OR'&5'L,?G]*\_P!.L+G5M1M]/LD\RYN'"(H]?4^PZFN_ 9="G4EBJGQ/
M;R5OS?Y&.,S&=2C'"4_A6_F[_DOS.G^'?@]O%FOCST/]FVA#W+=F]$_'O[5]
M)HBQHJ(H5%&%4#  ]*Q_"WARU\+:#!IMMABHW2RXYDD/5C_GIBMJLL37]K._
M1;"H4O9QMU"N.^*?_).=5^D?_H:UV-<;\5#CX<ZKGTC_ /0UK*A_%CZHNK\#
M]#YMKWGX2:I86?@:.*YNX8I/M$IVNX!QFO!-Z_WA^==OX8*G1$Y'^L;^=?0U
MJ*K1Y6['S\\5+#+GBK]#W>YU?0)X]MQ>6CK[L#7*ZK=^%U#&VN+AW[+",K^;
M5Q61[5)'#+,P6*)Y">RJ37!+)\-+6IK]Q$>(<7'2DK?>R66=9"<(1Z9-,MK>
M2ZN4AMXBTKG  Y-;FG>#=6OV!DB^S1'JTO7\J[W1?#EEHL?[I=\Q'S2MU/\
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DS+N-VT_&%*V_!<\\L>]%%%%&E"I34Y+5A7JSIU'"#T7H?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
